Prosecution Insights
Last updated: April 19, 2026

Examiner: FAN, LYNN Y

Tech Center 1700 • Art Units: 1651 1759

This examiner grants 47% of resolved cases

Performance Statistics

46.8%
Allow Rate
-18.2% vs TC avg
522
Total Applications
+48.7%
Interview Lift
1380
Avg Prosecution Days
Based on 472 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
11.2%
§102 Novelty
45.5%
§103 Obviousness
25.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18747769 COLLAGEN FIBERS AND ARTICLES FORMED THEREFROM Final Rejection EDWARDS LIFESCIENCES CORPORATION
18004556 Compositions and Methods for Inhibiting and Treating Coronavirus Infections Non-Final OA The Regents of the University of California
17439134 METHODS OF OBTAINING LIPIDS FROM A MICROBIAL CELL COMPOSITION Final Rejection DSM IP Assets B.V.
18325470 DISHWASHING DETERGENT COMPOSITION COMPRISING XYLANASE AND BLOCK CO-POLYMER Non-Final OA The Procter & Gamble Company
18208394 METHODS FOR CHARACTERIZING HOST-CELL PROTEINS Non-Final OA Regeneron Pharmaceuticals, Inc.
18199277 FOOD PRODUCTION SYSTEM, COMPOSITIONS, AND METHODS OF USING THE SAME Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18594957 COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS Non-Final OA AgroSpheres, Inc.
17855141 POROUS GLASS-BASED MICROBIAL STORAGE AND DELIVERY SYSTEM Final Rejection BATTELLE SAVANNAH RIVER ALLIANCE, LLC
18036474 COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS Final Rejection SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
17797968 COMPOSITION OF LACTIC ACID BACTERIUM FOR USE IN PREVENTING OR TREATING RETT SYNDROME Final Rejection National Taiwan University
18009485 FLUID GEL COMPOSITIONS Non-Final OA The University of Birmingham
18009144 FLUID GEL COMPOSITIONS Non-Final OA The University of Birmingham
18256867 REGENERATIVE TISSUE MANUFACTURING PROCESS Non-Final OA Vascudyne, Inc.
18278911 A CLOCK OSCILLATOR FOR BIOCHEMICAL REACTION COMPUTERS Final Rejection SOUTH CHINA UNIVERSITY OF TECHNOLOGY
18424524 MOLECULAR PROBES FOR MAPPING BIOLOGICAL ACTIVITY Final Rejection Trustees of Boston University
18010761 IMPROVED FIBER-WASHING IN CORN WET-MILLING Final Rejection Novozymes A/S
17915652 SUBMERGED FERMENTATION PROCESS Final Rejection Novozymes A/S
17913103 CLEANING COMPOSITIONS COMPRISING POLYPEPTIDES HAVING FRUCTAN DEGRADING ACTIVITY Non-Final OA Novozymes A/S
18288361 PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS Non-Final OA SYNBALANCE SRL
18620513 COMPOSITION COMPRISING BOTULINUM TOXIN Non-Final OA MERZ PHARMA GMBH & CO. KGAA
18425886 OXYGEN SCAVENGERS FOR ELECTROCHEMICAL BIOSENSORS Non-Final OA Maria Gabriela Machado de Almeida
18060134 METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS Final Rejection Research Development Foundation
18010076 METHODS FOR TESTING ANDEXANET POTENCY Final Rejection Alexion Pharmaceuticals, Inc.
17992331 Spray-Dried Tetrasaccharides Final Rejection Chr. Hansen A/S
18541250 BIOEFFECTIVE KRILL OIL COMPOSITIONS Final Rejection Aker BioMarine Human Ingredients AS
18233680 PROTEASE COMPOSITIONS AND METHODS OF USE Non-Final OA Swiss-American CDMO, LLC
17914275 METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASE Final Rejection Talengen International Limited
18249545 COMPOSITION FOR THE TREATMENT OF BIOLOGICAL, CYTOLOGICAL, HISTOLOGICAL AND AUTOPSICAL SAMPLES Non-Final OA DIAPATH S.P.A.
18249182 PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION Non-Final OA UNIVERSITE CATHOLIQUE DE LOUVAIN
17626622 AGENT FOR REGULATING FEMALE HORMONE SECRETION AND AGENT FOR ALLEVIATING UNPLEASANT SYMPTOMS Final Rejection Tokushima University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month